A
43
-3
DD
40
-2
AMG
49
-3
EQT
42
-3
BA
54
-4
MSFT
51
-3
MSI
50
-2
FAST
38
-2
ALL
35
-2
VTR
41
-2
FOX
62
-8
R
60
-3
SBUX
27
-12
CVX
14
-3
FSLR
44
-2
DVN
14
-8
MUR
31
-9
WBA
38
-5
C
51
-3
HST
50
-2
A
43
-3
DD
40
-2
AMG
49
-3
EQT
42
-3
BA
54
-4
MSFT
51
-3
MSI
50
-2
FAST
38
-2
ALL
35
-2
VTR
41
-2
FOX
62
-8
R
60
-3
SBUX
27
-12
CVX
14
-3
FSLR
44
-2
DVN
14
-8
MUR
31
-9
WBA
38
-5
C
51
-3
HST
50
-2
Financhill
Back

Takeda Pharmaceutical 10K Form

Sell
39

TAK
Takeda Pharmaceutical

Last Price:
$13.18
Seasonality Move:
5.64%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TAK News And Ratings

See the #1 stock for the next 7 days that we like better than TAK

TAK Financial Statistics

Sales & Book Value

Annual Sales: $29.5B
Cash Flow: $1.3B
Price / Cash Flow: 12.28
Annual Sales: $15.29
Price / Book: 0.87

Profitability

EPS (TTM): 0.60440
Net Income (TTM): $1.9B
Gross Margin: $19.7B
Return on Equity: 4.01%
Return on Assets: 1.91%

Takeda Pharmaceutical Earnings Forecast

Key Takeda Pharmaceutical Financial Ratios

  • The Gross Profit Margin over the past 25 years for TAK is 66.54%.
  • The Selling, General & Administrative Expenses for TAK have been equal to 24.72% of Gross Profit Margin.
  • The Research & Development expenses have been 17.12% of Revenue.
  • The Interest Expense is 82.97% of Operating Income.
  • The Net Earning history of TAK is 3.38% of Total Revenues.
  • Per Share Earnings over the last 25 years have been positive in 15 years.

Takeda Pharmaceutical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: TAK
CUSIP: 874060
Website: takeda.com

Debt

Debt-to-Equity Ratio: 0.73
Current Ratio: 1.28
Quick Ratio: 0.68

Price-to-Earnings

Trailing P/E Ratio: 42.01
Forward P/E Ratio: 0

TAK Technical Analysis vs Fundamental Analysis

Sell
39
Takeda Pharmaceutical (TAK) is a Sell

Is Takeda Pharmaceutical a Buy or a Sell?